U.K. study makes case for AstraZeneca booster shot
The Hindu
A third dose of both the AstraZeneca and Pfizer-BioNTech COVID-19 vaccines significantly increased the immune response to the Omicron variant, according to a new study by University of Oxford research
A third dose of both the AstraZeneca and Pfizer-BioNTech COVID-19 vaccines significantly increased the immune response to the Omicron variant, according to a new study by University of Oxford researchers.
The laboratory study, which has not been peer reviewed yet, compared antibody levels in blood samples from people who received two doses of vaccine with samples from those who had received a third dose.
More Related News

U.S. President Donald Trump threatens 200% tariff on wine, champagne from France, other EU countries
Trump threatens 200% tariffs on European alcohol in response to EU levies, sparking trade tensions and market uncertainty.